Cristina Saura Archives

DESTINY-Breast06: results support the use of trastuzumab deruxtecan in earlier lines of treatment for patients with metastatic breast cancer

Recently published in The New England Journal of Medicine, results from the phase 3, multicenter DESTINY-06 clinical trial show that…

Follow-up from the POSITIVE study: latest results suggest that breastfeeding in women with hormone receptor-positive early breast cancer is possible and does not impact on prognosis

Among the 518 women enrolled in the international POSITIVE clinical trial with hormone receptor-positive early breast cancer who temporarily interrupted…

VHIO discovers potential use of breast milk liquid biopsy for the early diagnosis of breast cancer

Researchers at the Vall d’Hebron Institute of Oncology (VHIO), part of the Vall d’Hebron Campus, have found that breast milk…

POSITIVE results show that temporarily discontinuing endocrine therapy to attempt pregnancy after breast cancer does not increase the short-term risk of disease relapse

Published in The New England Journal of Medicine (1), first results of the international POSITIVE study co-authored by VHIO’s Cristina…

SABCS 2022: POSITIVE study shows that interruption of endocrine therapy in breast cancer patients planning pregnancy does not result in worse short-term disease relapse

Presented at the 45th annual San Antonio Breast Cancer Symposium® (2022 SABCS®), primary results of the multicenter international POSITIVE study…

VHIO investigators co-author new ESMO Clinical Practice Guideline with evidence-based recommendations for the treatment of metastatic breast cancer

Marking this October’s Breast Cancer Awareness Month, the new ESMO Clinical Practice Guideline for metastatic breast cancer has just published…